Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinoma

Cancer

Volumn 83, Issue 12, 1998, Pages 2521-2527

  Shering, S G ^a   Sherry, F ^a   McDermott, E W ^a   O'Higgins, N J ^a   Duffy, M J ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Breast carcinoma; CA 15 3; Mucin; Prognosis

Indexed keywords

CA 15-3 ANTIGEN; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS; CA-15-3 ANTIGEN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 0032535072     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981215)83:12<2521::AID-CNCR17>3.0.CO;2-A     Document Type: Article

References (19)